4 left
Ipamorelin
£18
- Home
- Somatotropic
- CJC-1295 No DAC
In stock, ships today
- Purity: ≥99% (HPLC)
- Form: White lyophilised powder
- Independent lab report for the batch you receive
- For laboratory research use only
£25
- Sold out.
- Order within 12h 10m for dispatch today, estimated delivery Thu 12 Nov
- Free UK delivery over £100
- Discreet, plain unbranded packaging
Third-party lab report
Batch CJN5.121 99% purity Tested 16 Mar 2026
Pay by bank
About CJC-1295 No DAC
CJC-1295 (without DAC), also known as Modified GRF 1-29, is a synthetic tetrasubstituted analogue of Growth Hormone Releasing Hormone (GHRH). The peptide corresponds to the first 29 amino acids of GHRH (the bioactive core), with four amino acid substitutions designed to enhance resistance to enzymatic cleavage by DPP-IV in research applications.
Primary areas of investigation
- GHRH receptor signalling research
- Pituitary somatotroph cell studies
- Pulsatile secretion pattern models
- DPP-IV enzymatic resistance research
- GHRH/GHRP co-administration studies
- Somatotropic axis cell research
Mechanism
Research into CJC-1295 No DAC examines its function as a selective agonist of the GHRH receptor in preclinical models. In experimental systems, it is investigated for its association with pituitary somatotroph cell signalling and pulsatile secretion pattern research. The compound is frequently studied in combination with GHRPs (such as Ipamorelin) to investigate signalling interactions on the somatotropic axis.
Delivery and returns
Shipped in plain, unbranded packaging from our United Kingdom warehouse. Damaged on arrival? Tell us within 48 hours and we’ll put it right. Shipping and returns
For laboratory research use only. Not for human or veterinary use.
